New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
08:41 EDTBCLIBrainStorm Cell announces first patient enrollment in Phase II ALS trial
BrainStorm Cell announced that the first patient was enrolled in its Phase II ALS trial at Massachusetts General Hospital. BrainStorm's Phase II trial is a randomized, double-blind, placebo controlled multi-center study designed to evaluate the safety and efficacy of transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors in 48 ALS patients. The trial is also being conducted at the University of Massachusetts Memorial Hospital and the Mayo Clinic in Rochester, Minnesota.
News For BCLI From The Last 14 Days
Check below for free stories on BCLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
06:10 EDTBCLIBrainStorm Cell announces 1-for-15 reverse stock split
Brainstorm Cell announced that on September 15, it plans to effect a 1-for-15 reverse split of its issued and outstanding common stock as part of its intended plan to pursue a stock listing on the NASDAQ Capital Market.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use